Alternative treatment options for CLL
How does a patient’s personal situation affect CLL treatment choice?
Overview of a Phase Ib study of venetoclax and obinutuzumab in CLL
The success story of indolent disease treatment expanded to difficult-to-treat patient groups
Importance of taking into consideration new and traditional treatment options for CLL patients